Rafael Holdings, Inc.
RFL
Rank in Stocks
#22260
Rafael Holdings, Inc. holds strategic investments in both early-stage and... Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Share Price
$1.07
Last synced: 2026-11-13
Market Cap
$54.99M
Change (1 day)
-3.60%
Change (1 year)
-12.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Rafael Holdings, Inc. (RFL)
Category
Real Estate
EPS for Rafael Holdings, Inc. (RFL)
EPS as of July 2026 TTM: $-0.58
According to Rafael Holdings, Inc.'s latest financial reports, its current EPS (TTM) is $-0.58. At the end of 2025 the company had an EPS of $-1.04, an increase over its 2024 EPS of $-1.45.
EPS history for Rafael Holdings, Inc. from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.58 | -44.23% |
| 2025 | $-1.04 | -28.28% |
| 2024 | $-1.45 | 1,699.01% |
| 2023 | $-0.08 | -98.72% |
| 2022 | $-6.31 | 329.25% |
| 2021 | $-1.47 | 234.09% |
| 2020 | $-0.44 | 18.92% |
| 2019 | $-0.37 | -60.22% |
| 2018 | $-0.93 | -8,554.55% |
| 2017 | $0.01 | -80.57% |
| 2016 | $0.06 | -251.34% |
| 2015 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $4.70 | -910.34% |
US
|
|
| $1.05 | -281.03% |
BM
|
|
| $0.66 | -213.19% |
CN
|
|
| $1.02 | -276.17% |
DE
|
|
| $23.55 | -4,160.34% |
US
|
Questions about Rafael Holdings, Inc.'s earnings per share (EPS)
What is Rafael Holdings, Inc.'s earnings per share (EPS)?
Rafael Holdings, Inc.'s earnings per share (EPS) over the last twelve months is $-0.58, as of Jul 2026.
What was Rafael Holdings, Inc.'s earnings per share (EPS) in 2025?
In 2025, Rafael Holdings, Inc.'s earnings per share (EPS) was $-1.04, compared with $-1.45 in 2024.
How has Rafael Holdings, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Rafael Holdings, Inc.'s earnings per share (EPS) was highest in 2023 ($-0.08) and lowest in 2022 ($-6.31).
How does Rafael Holdings, Inc.'s earnings per share (EPS) compare with similar companies?
Rafael Holdings, Inc.'s earnings per share (EPS) ($-0.58) is lower than that of all 5 similar companies listed above. The highest among them is Jones Lang LaSalle Incorporated, with $23.55.